Immunotherapy in ovarian, endometrial and cervical cancer: state of the art and future perspectives

The tumors of the female genital tract represent a huge health problem in Europe, Endometrial Cancer, EC, with 6.1% of cases estimated in 2012 [1] is the most common, followed by Epithelial Ovarian Cancer, EOC, and Cervical Cancer, CC; those malignancies have distinct biology and molecular features and differ from each other based on clinical behavior, nevertheless all them are associated with high mortality. Important goals have been achieved in CC prevention and treatment: the worldwide spreading of the Papanicolaou test, PAP test, has dramatically increased the rate of diagnosis for precancerous conditions/early stage tumors and the extensive HPV (Human Papillomavirus) vaccination programs are expected to produce a massive decrease in the incidence of CC in the next few years.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2uevky9
via IFTTT